Industry · Pharmaceutical

Virtual CFOs for pharma — multi-entity, regulator-ready, margin-aware.

Compliance reporting, multi-entity consolidation, and margin diagnostics for pharma companies that have outgrown their in-house finance team.

Pharma is finance-heavy, regulation-heavy, and frequently multi-entity. The same finance leader has to talk to SAHPRA, the FDA, the auditor, and the bank in the same week. We bring an Advisory Specialist for the margin diagnostics, a Virtual CFO for the multi-entity story, and an FP&A specialist for the scenarios.

Where it hurts

The pharmaceutical pains we step into.

  • Fuel and logistics cost shocks

    Cold-chain logistics doesn't reprice on a 30-day notice. We model the shock against your gross margin so the price-list conversation has data behind it.

  • Compliance reporting (SAHPRA / FDA / EMA)

    Regulator reporting has its own calendar, its own definitions, and almost no overlap with your management pack. We separate them cleanly so audit-time isn't crisis-time.

  • Multi-entity consolidation

    ZA + offshore subsidiary + a captive distributor + a holdings company is normal in pharma. A clean consolidation pack is not. We build one.

  • Pricing under medical aid / insurance pressure

    Net-net price after rebates is the only price that matters. We track it per SKU and surface where you're funding someone else's margin.

Most-relevant seats

The right people for pharmaceutical.

Ready to put a specialist on your pharmaceutical team?

Walk into the boardroom. Pick the seat. Book the free consultation.

Take me to the boardroom